Benign neoplasm of major salivary glands
Chapter 2:Neoplasms
ICD-10 D11 is a billable code used to indicate a diagnosis of benign neoplasm of major salivary glands.
Benign neoplasms of the major salivary glands, including the parotid, submandibular, and sublingual glands, are non-cancerous tumors that can arise from various cell types within these glands. Common types include pleomorphic adenomas, which are the most prevalent, and other less common forms such as Warthin's tumor and oncocytoma. These neoplasms may present as painless swellings in the affected gland and can vary in size. While benign, they may cause discomfort or functional issues, such as difficulty swallowing or speaking, depending on their size and location. Surveillance is essential as some benign tumors can exhibit atypical features that may raise concerns for malignant transformation. Regular follow-up with imaging studies and clinical evaluations is recommended to monitor for any changes in size or characteristics. Surgical excision is often the treatment of choice, particularly if the neoplasm causes symptoms or if there is uncertainty regarding its nature. Accurate coding is crucial for appropriate management and reimbursement.
Detailed descriptions of the tumor's size, location, and symptoms, along with imaging results.
Patients presenting with painless swelling in the parotid gland, or recurrent infections in the submandibular gland.
Ensure that the documentation clearly indicates the benign nature of the neoplasm and any surgical interventions performed.
Histopathological reports confirming the benign nature of the neoplasm.
Reviewing biopsy specimens from patients with suspected salivary gland tumors.
Accurate reporting of tumor type and characteristics is essential for proper coding.
Used in cases of obstructive sialadenitis or to manage complications of benign neoplasms.
Document the indication for the procedure and any pre-operative imaging.
Otolaryngologists should ensure that the procedure is justified based on clinical findings.
The most common types include pleomorphic adenomas, Warthin's tumors, and oncocytomas. Each has distinct characteristics and may require different management approaches.
Patients should be monitored regularly, typically every 6 to 12 months, with imaging studies to assess for any changes in size or characteristics of the neoplasm.
